Sharon Mates CEO ofIntraCellular Therapies Inc

firms to help Cuba improve environmental practices in off-shoreenergy exploration; and, Lifting sanctions against future ethanol imports from Cuba to the U.S.To improve our knowledge about extreme weather conditions in the Gulf of Mexicoand Cubas civil defense program, the report suggests: Allowing Cuban scientists and emergency managers to visit the U.S. and shareinformation on evacuation plans, post-disaster medical support, and citizendisaster preparedness education programs; and, Permitting U.S. scientists and emergency managers to visit Cuba and observestorm evacuations in real time.To engage the Cuban-American community and change the tone of U.S.-Cubarelations, the reports recommendations include: Eliminating restrictions on Cuban-Americans to visit the island and providefinancial support; Shutting down TV Marti; and, Shutting down Radio Marti or transferring its management to the Voice ofAmerica in Washington.Essays in the report were written by Sarah Stephens, Alan Webber, Gen. James T.Hill, Randy Beardsworth, Robert Bach, Peter Bourne, Jake Colvin, Ivor vanHeerden, Amy Myers Jaffe and Ronald Soligo, Franklin W Knight, Alberto R Coll,and Louis A.

Since 2001, the Freedom to Travel campaign hastaken bi-partisan delegations to Cuba that included 5 U.S Senators, 28 Membersof Congress, and 30 professional staff. Learn more about The Center for Democracy in the Americas by visiting itswebsite: The Center for Democracy in the Americas (CDA)Collin Laverty, 202-234-5506 Copyright Business Wire 2009. NEW YORK(Business Wire)New York Biotechnology Association (NYBA), the voice of New York Statesbiotechnology industry, today announced that Dr. Sharon Mates, CEO ofIntra-Cellular Therapies Inc., has been elected Chairman of the Board for2009-2010. The Association also announced the appointments of Robert Easton,Chairman of Scisive Consulting, and Barbara Gebhardt, President of OpusScientific, to the Board of Directors Dr. Her business acumen combined with herlong-time support for the Association will be a great asset as the industryaddresses todays economic challenges.

I am also pleased to welcome RobertEaston and Barbara Gebhardt to the Board and thank them for bringing theirskills and experience to NYBA. Their track records of professional achievementand intricate knowledge of the complex issues facing todays biotechnologyindustry will further broaden the capabilities of our association as we work toenable a new platform for growth." Along with the new appointments, NYBAs Executive Committee has also beenrevised. Mates is the Chairman and CEO of Intra-Cellular Therapies, Inc (ITI) From1989 to 1998, Dr. Mates was the President of North American Vaccine and itspredecessor companies Since 1998, Dr. Allen Feinberg ofRockefeller University to develop new therapeutics for CNS diseases based onproprietary technologies developed in Dr Greengard's laboratory Dr. fromthe University of Washington and was a postdoctoral fellow and fellow at HarvardMedical School and the Massachusetts General Hospital. Robert J.

Easton, Chairman, Scisive ConsultingFor over 25 years, Bob Easton has been recognized as a global leader inhealthcare business consulting. He has advised and supported hundreds of clientexecutives in North America, Europe, Israel, and Asia. His interest inhealthcare began when he managed a medical diagnostics business for UnionCarbide Mr. Easton has been highly visible in the industry, having written and spokenabout multiple industry issues in scores of venues. He has served on 8 medicalcompany Boards including Apex Bioventures, CollaGenex, and Cepheid. He alsoserves as Chairman of Gildas Club of New York City, which provides social andemotional support to people living with cancer Mr. Easton holds two degrees inChemical Engineering from Rice University and an MBA from the Harvard BusinessSchool. Barbara Gebhardt, President, Opus StaffingBarbara Gebhardt began her career with Career Blazers in the 1980s.